ORGANIC IRON COMPOUND NU LIFE 200 MG
LIVER EXTRACT : 200 MG ASCORBIC ACID (ROSE HIPS) : 50 MG FOLIC ACID (LIVER) : .1 MG VITAMIN B12 (VITAMIN B12) : .01 MG MANGANESE (MANGANESE GLUCONATE) : 2 MG COPPER (COPPER GLUCONATE) : .5 MG IRON (FERROUS FUMARATE) : 60 MG BIOFLAVONOIDS : 25 MG · DIN 00065196 · NU-LIFE NUTRITION LTD.
Health Canada status: CANCELLED POST MARKET
What is ORGANIC IRON COMPOUND NU LIFE?
ORGANIC IRON COMPOUND NU LIFE 200 MG contains LIVER EXTRACT : 200 MG ASCORBIC ACID (ROSE HIPS) : 50 MG FOLIC ACID (LIVER) : .1 MG VITAMIN B12 (VITAMIN B12) : .01 MG MANGANESE (MANGANESE GLUCONATE) : 2 MG COPPER (COPPER GLUCONATE) : .5 MG IRON (FERROUS FUMARATE) : 60 MG BIOFLAVONOIDS : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 00065196, held by NU-LIFE NUTRITION LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 03-Mar-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00065196 |
|---|---|
| Brand name | ORGANIC IRON COMPOUND NU LIFE |
| Generic / active ingredient | LIVER EXTRACT : 200 MG ASCORBIC ACID (ROSE HIPS) : 50 MG FOLIC ACID (LIVER) : .1 MG VITAMIN B12 (VITAMIN B12) : .01 MG MANGANESE (MANGANESE GLUCONATE) : 2 MG COPPER (COPPER GLUCONATE) : .5 MG IRON (FERROUS FUMARATE) : 60 MG BIOFLAVONOIDS : 25 MG |
| Manufacturer | NU-LIFE NUTRITION LTD. |
| Strength | 200 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | B03AA52 FERROUS FUMARATE, COMBINATIONS |
| AHFS class | 20:04.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 03-Mar-2000 |
| Original market date | 1963-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B03AA52 FERROUS FUMARATE, COMBINATIONS. 0 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FORTIPLEX | 15 MG | TABLET | SANTÉ NATURELLE (AG) LTÉE | CANCELLED POST MARKET | DIN 00598631 |
| TRI 88 SRC | 5 MG | CAPSULE (SUSTAINED-RELEASE) | ANABOLIC LABORATORIES INC. | CANCELLED POST MARKET | DIN 00279463 |
Who else supplies FERROUS FUMARATE, COMBINATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FERROUS FUMARATE, COMBINATIONS appears in 75 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.